Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)

Abstract

Hematopoietic Stem Cell Transplantation (HSCT) is the only potentially curative treatment option for the hematologic complications that occur in patients with Fanconi anemia (FA). In this study, we present a retrospective multicenter analysis from the Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT) of matched related donor HSCT for FA in adolescents and adults transplanted between 1988 and 2015. Forty-five patients received HSCT with a median age at transplant of 18 years, the interquartile range (IQR) (15–23.5); 25 (55.6%) patients were females and 20 (44.4%) were males. Conditioning regimen was fludarabine-based in 29 (64.4%) patients, irradiation-based in five (11.1%) patients, and the remaining patients received other combinations. Indication for HSCT was bone marrow failure in 39 (86.7%) and myelodysplastic syndrome in six (13.3%) patients. Stem cell source was bone marrow in 22 (48.9%), peripheral blood in 20 (44.4%), umbilical cord blood in one (2.2%), and combination of bone marrow and cord blood in two (4.4%) patients. Twenty-seven (60%) patients engrafted and five (11.1%) had primary engraftment failure. The median time to neutrophil engraftment was 14 days (range 10–21 days); median time for platelet engraftment was 17 days (10–33 days). The probability of developing grade II–IV acute GVHD for all patients was 7.0% and chronic GVHD 36.6%. No new malignancies were reported. The OS probability was 53.6% (95% CI, 38.3–68.9%) with a median follow-up of 13 months (95% CI, 1–240). Our HLA-matched related HSCT results in AYA patients with FA compare favorably with other reported international registry data.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: OS for entire cohort.

References

  1. 1.

    Fanconi G. Familial constitutional panmyelocytopathy, Fanconi’s anemia (F.A.). I. Clinical aspects. Semin Hematol. 1967;4:233–40.

    CAS  PubMed  Google Scholar 

  2. 2.

    Alter BP. Fanconi’s anemia and malignancies. Am J Hematol. 1996;53:99–110. e-pub ahead of print 1996/10/01; 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.0.CO;2-Z

    CAS  Article  Google Scholar 

  3. 3.

    Alter BP. The bone marrow failure syndromes. In: Nathan DG, Oski FA, editors. Hematology of infancy and childhood. Philadelphia, PA: Saunders; 2003. p. 237.

  4. 4.

    Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry Study. Blood. 1994;84:1650–5. e-pub ahead of print 1994/09/01

    CAS  Article  Google Scholar 

  5. 5.

    Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249–56. https://doi.org/10.1182/blood-2002-07-2170. e-pub ahead of print 2002/10/24

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822–6. https://doi.org/10.1182/blood-2002-05-1498. e-pub ahead of print 2002/10/24

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Socie G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, et al. Transplantation for Fanconi’s anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol. 1998;103:249–55. e-pub ahead of print 1998/10/29

    CAS  Article  Google Scholar 

  8. 8.

    MacMillan ML, Davies SM, Orchard PJ, Ramsay NK, Wagner JE. Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia. Br J Haematol. 1998;103:552–8. e-pub ahead of print 1998/11/25

    CAS  Article  Google Scholar 

  9. 9.

    Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol. 1980;45:565–8. e-pub ahead of print 1980/08/01

    CAS  Article  Google Scholar 

  10. 10.

    Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54:431–40. e-pub ahead of print 1983/07/01

    CAS  Article  Google Scholar 

  11. 11.

    Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386–92. e-pub ahead of print 1996/01/01

    CAS  Article  Google Scholar 

  12. 12.

    Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemia. Bone Marrow Transpl. 1997;20:1109–10. https://doi.org/10.1038/sj.bmt.1701016. e-pub ahead of print 1998/02/18

    CAS  Article  Google Scholar 

  13. 13.

    Aker M, Varadi G, Slavin S, Nagler A. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol. 1999;21:237–9. e-pub ahead of print 1999/06/11

    CAS  Article  Google Scholar 

  14. 14.

    Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A, et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transpl. 2006;12:712–8. https://doi.org/10.1016/j.bbmt.2006.03.002. e-pub ahead of print 2006/06/21

    CAS  Article  Google Scholar 

  15. 15.

    Maschan AA, Trakhtman PE, Balashov DN, Shipicina IP, Skorobogatova EV, Skvortsova YV, et al. Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. Bone Marrow Transpl. 2004;34:305–7. https://doi.org/10.1038/sj.bmt.1704580. e-pub ahead of print 2004/06/15

    CAS  Article  Google Scholar 

  16. 16.

    Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer. 2006;46:630–6. https://doi.org/10.1002/pbc.20538. e-pub ahead of print 2005/08/04

    Article  PubMed  Google Scholar 

  17. 17.

    Ben Halim N, Hsouna S, Lasram K, Rejeb I, Walha A, Talmoudi F, et al. Differential impact of consanguineous marriages on autosomal recessive diseases in Tunisia. Am J Hum Biol. 2016;28:171–80. https://doi.org/10.1002/ajhb.22764. e-pub ahead of print 2015/07/17

    Article  PubMed  Google Scholar 

  18. 18.

    Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji RM, Bazarbachi A, et al. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011–2012: a comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT). Hematol Oncol Stem Cell Ther. 2015;8:167–75. https://doi.org/10.1016/j.hemonc.2015.09.002. e-pub ahead of print 2015/10/11

    Article  PubMed  Google Scholar 

  19. 19.

    Bierings M, Bonfim C, Peffault De Latour R, Aljurf M, Mehta PA, Knol C, et al. Transplant results in adults with Fanconi anaemia. Br J Haematol. 2018;180:100–9. https://doi.org/10.1111/bjh.15006. e-pub ahead of print 2017/11/03

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Peffault de Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122:4279–86. https://doi.org/10.1182/blood-2013-01-479733. e-pub ahead of print 2013/10/23

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86:2856–62. e-pub ahead of print 1995/10/01

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ghuzayel AlDawsari.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

AlDawsari, G., Elhaddad, A., El Fakih, R. et al. Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT). Bone Marrow Transplant 55, 1485–1490 (2020). https://doi.org/10.1038/s41409-020-0809-5

Download citation

Further reading

Search